Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

Banyu scientists prepare and test new glucokinase activators

Nov. 5, 2004

Novel 5-HT2C receptor ligands and their use described in GSK patent

Nov. 5, 2004

New SGLT2 inhibitors claimed by Yamanouchi and Kotoboki

Nov. 5, 2004

Two novel series of PPARdelta agonists developed at Ono

Nov. 5, 2004

New analgesic agents targeting neuropeptide FF receptors

Nov. 5, 2004

New opioid antagonists and their use as antiobesity agents

Nov. 5, 2004

Lundbeck claims new KCNQ channel activators for epilepsy and other disorders

Nov. 5, 2004

Novel DPP-IV inhibitors identified by Kotobuki researchers

Nov. 5, 2004

NeuroSearch scientists prepare and test new KCNQ channel modulators

Nov. 4, 2004

KuDOS and Maybridge collaborate to develop new PARP inhibitors

Nov. 4, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 29, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...